Top Back to top

Meet the Expert Sessions

Meet the Expert sessions are an opportunity for delegates to sit down and converse on a more one-to-one level with the experts in their field. They take place on the Monday, Tuesday and Wednesday of the meeting, from 08:00 - 09:00.

Please note that Meet the Expert sessions are not included in the general Meeting registration fee, and must be purchased separately. The fee is €30 (VAT included) per session. Tickets are available on a first-come, first-served basis. 


For the first time this year, supporting companies provide additional Meet the Expert sessions over lunch on Monday and Tuesday. Pre-registration is required via the general registration form. For further information, please check our Industry Meet the Expert lunch sessions here.

Monday, August 31st

MTE-1 Viral infections in HSCT recipients: the challenges in 2020 Francisco Marty (US) A10.01
MTE-2 Extracorporeal Photopheresis in the Management of Acute and Chronic GvHD Daniel Couriel (US) A10.05
MTE-3 The role of donor registries in the changing landscape of allogeneic HSCT in 2020 Enric Carreras (SP) A10.06
MTE-4 How to manage chronic GvHD in 2020 and beyond Steven Pavletic (US) A10.07
MTE-5 The role of cord blood banks in the changing landscape of allogeneic HSCT in 2020? Sergi Querol (SP) A10.12
MTE-6 How to establish a CAR T Cell Delivery Centre Claire Roddie (UK) A10.13
MTE-7 How to manage Acute Promyelocytic Leukemia in 2020. Current role of Hematopoietic Cell Transplantation Miguel Ángel Sanz (SP) A10.15

Tuesday, September 1st

CODE topic expert room
MTE-8 HSCT in high-risk MDS David Valcárcel (SP) A10.01
MTE-9 Prophylaxis of acute graft versus host disease: ATG or not ATG? Francesca Bonifazi (IT) A10.05

Clinical Hurdles for Academic Development of Clinical Advanced Therapies: the perspective from the GMP Lab

Fermín Sánchez-Guijo (SP) A10.06
MTE-11 The fast changing paradigm of myeloma treatment: what's best in 2020? Sergio Giralt (US) A10.07
MTE-12 How I manage double hit lymphomas Andrew Davies (UK) A10.12
MTE-13 The role of HSCT in Mantle Cell Lymphoma in 2020 Olivier Hermine (FR) A10.13
MTE-14 Maintenance strategies after allogeneic HSCT in patients with AML Ali Bazarbachi (LB) A10.15

Wednesday, September 2nd

code topic expert room
MTE-15 Fungal infections in HSCT recipients - the challenges in 2020 Livio Pagano (IT) A10.01
MTE-16 HSCT and gene therapy in inherited metabolic diseases Robert Wynn (UK) A10.05
MTE-17 Current challenges facing emerging donor registries in 2020 Mahmoud Aljurf (SA) A10.06
MTE-18 HSCT indications in paediatric MDS Charlotte Niemeyer (DE) A10.07
MTE-19 Ex vivo cellular manipulation and therapy as the platform of choice for allogeneic HSCT in 2020 Stephan Mielke (SE) A10.12
MTE-20 Current role of mesenchymal stromal cells in HSCT Peter Bader (DE) A10.13

HSCT in MS and immune-mediated neurological diseases: patient selection and follow-up

Basil Sharrack (UK) A10.15


Quality Management Meet the Expert Sessions

These sessions are free of charge and take place on the Tuesday of the meeting from 13:00 - 14:00. Pre-registration is required via the general registration form, under the Quality Management Group category.


Tuesday, September 1st

QM MTE 1 Risk & Change Management Dieter Klarmann (DE)
Olga López Villar (SP)
QM MTE 2 Audits & Document development and control Renza Monteleone (IT)
Julie Dolva (NO)
QM MTE 3 Adverse events & CAPA Anne Emmett (UK) A10.07
QM MTE 4 Maintaining the QM program and QM plan Nick van Sinderen (NL)
Phuong Huynh (BE)
QM MTE 5 Outcome analysis and benchmarking & Validation and verification Mara Magri (IT)
Kim Orchard (UK)
QM MTE 6 Personnel, Training and Competency Ilknur Kozanoglu (TR)
Songül Tepebasi (TR)